StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Viatris Inc.
NasdaqGS:VTRS
Sector
Location
Market Cap
USD 10.84 B
Share Price
USD 9.24
Avg Daily Volume
14,392,880
Change (1 day)
3.82%
Change (1 year)
-20.82%
Change (YTD)
-25.78%
Viatris Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 1.58
Viatris Inc. Current Ratio is 1.58 for the Trailing 12 Months (TTM) ending March 31, 2025, a -2.00% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
-
Viatris Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 1.61, a 4.09% change year over year.
-
Viatris Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 1.55, a 34.82% change year over year.
-
Viatris Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 1.15, a 2.57% change year over year.
-
Viatris Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 1.12, a -14.66% change year over year.
Competitors
Eli Lilly and Company
USD 776.44
LLY
+14.26
1.87%
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
Cencora, Inc.
USD 292.97
COR
+0.30
0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%
Haleon plc
USD 4.80
HLN.L
+0.02
0.48%
Daiichi Sankyo Company, Limited
USD 24.77
4568.T
+0.95
3.97%
Ucb S.A.
USD 202.82
UCB.BR
+0.24
0.12%
BeOne Medicines Ltd.
USD 295.59
ONC
+3.66
1.25%
Key Data
| Date | Current Ratio | Interest Coverage Ratio | Return on Capital Employed (ROCE) | Return on Equity (ROE) |
|---|
Competitors
Eli Lilly and Company
USD 776.44
LLY
+14.26
1.87%
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
Cencora, Inc.
USD 292.97
COR
+0.30
0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%
Haleon plc
USD 4.80
HLN.L
+0.02
0.48%
Daiichi Sankyo Company, Limited
USD 24.77
4568.T
+0.95
3.97%
Ucb S.A.
USD 202.82
UCB.BR
+0.24
0.12%
BeOne Medicines Ltd.
USD 295.59
ONC
+3.66
1.25%